Pular para o conteúdo
Menu
Mix Vale

The fall of the semaglutide patent in March 2026 does not reduce the prices of weight-loss pens

Beatriz
Por 4 min de leitura
Compartilhe
Canetas emagrecedoras
Foto: Canetas emagrecedoras - Foto: Caroline Ruda/Shutterstock.com

The patent for semaglutide, the active ingredient present in Ozempic, Wegovy and The initial expectation of cheaper versions in pharmacies is not confirmed in the short term. Barreiras regulations, industrial complexity and the Danish manufacturer’s strategies limit immediate competition and keep values ​​high.

Publicidade

The drug has established itself as one of the best sellers in the weight control and type 2 diabetes segment. The Brazilian market for weight-loss pens doubled in revenue in 2025. The entry of similar national products should occur gradually. Novo Nordisk prepares local production in Minas Gerais to preserve its dominant position.

Main regulatory and industrial obstacles to launch

Anvisa analyzes 14 registration requests for the production of semaglutide in the country. The agency limits the number of approvals to a maximum of three per semester. Esse pace extends the release schedule until mid-2028. Empresas as EMS estimates that the first pens will only reach pharmacies in the second half of 2026.

Publicidade

Manufacturing requires industrial plants with rigorous sterility controls and stability testing. EMS allocated more than R$1.2 billion to the construction of a dedicated unit in Hortolândia. Novo Nordisk invests R$6.4 billion in a factory in Montes Claros. Esses high contributions explain part of the delay in offering affordable alternatives.

Mandatory discounts are limited in the similar category

National versions will be registered as similar, not as generic. The legislation provides for a minimum discount of 20% on the reference price for similar products. Genéricos would require a reduction of at least 35%, but few orders take this route. Most choose to maintain their own brand and differentiated packaging.

The list price of Ozempic is around R$1,300. Aplicando the mandatory discount, national pens could be sold from approximately R$1,040. Novo Nordisk already offers promotional prices close to R$999 in several pharmacy chains. Initial competition tends to keep prices in line with current levels.

Experience with liraglutide, an earlier molecule in the same class, shows modest reductions. Após eight months of similar products on the market, the average discount on list prices was 20.1%. Descontos reais, driven by promotions, reached 30% at times. The commercial strategy of manufacturers influences more than legal obligations.

Complexity of production and logistics prevents rapid price drops

The production of injectable pens requires continuous microbiological monitoring and extensive transport testing. The demands exceed those for medicines in tablets or simple solutions. Mandatory refrigeration throughout the logistics chain increases operational costs.

Publicidade

Few Brazilian laboratories have adequate infrastructure. EMS and Biomm stand out among those capable of producing at scale. Outras companies seek partnerships with Asian manufacturers to import inputs or ready-made products. Taxation on imports compromises the competitiveness of national versions.

Novo Nordisk advances its local production strategy. The company already distributes its products through partnerships with Brazilian laboratories. Manufacturing in national territory reduces external dependence and strengthens the response to future competition.

Limited national competition early in the process

The entry of multiple manufacturers faces technical and financial constraints. Muitas pharmaceutical companies gave up on their own production due to the necessary investment. Algumas opted for licensing or outsourcing abroad. EMS is moving forward with a dedicated factory, but the number of players remains small.

Novo Nordisk maintains a strong presence even after the end of the patent. The company can extend discounts or launch promotions to protect its market share. Analistas project that significant price reductions will only occur after a few years, when competition intensifies.

The weight loss pen market records accelerated growth in the Brasil. Sales of semaglutide increased significantly in 2025 and continue to rise. The projection points to annual revenue exceeding R$24 billion in 2026. The demand for obesity and diabetes treatments sustains industrial interest.

Other molecules and illegal sales influence the current market

Mounjaro, based on tirzepatide, has already surpassed semaglutide sales in recent months. The molecule shows greater weight reduction in clinical trials. Sua patent only expires in 2036, guaranteeing prolonged exclusivity. Novos drugs under development promise even more impressive results.

Oral options gain relevance as a practical alternative. Rybelsus, a semaglutide tablet, costs less than injectable pens. Ease of transportation and administration favors its gradual adoption. Moléculas future tablets should expand this trend.

The illegal sale of products manipulated or imported irregularly is growing in the country. Polícia Federal investigates cases of mass production in compounding pharmacies. Fabricantes officials reinforce actions against the parallel market to protect patient safety.

Publicidade

Beatriz Lima é colaboradora da redação do Mix Vale, portal de notícias com cobertura de Brasil e mundo. Produz conteúdo nas editorias de economia e benefícios, com foco em informação de serviço para o leitor brasileiro. Escreve para o portal desde 2024.

Notícias relacionadas

Mais lidas

  1. Ciência

    Meteoro no Nordeste: bólido cruza o céu de cinco estados às 21h34 e mobiliza buscas por fragmentos na Paraíba

  2. Caixa Econômica Federal

    Pé-de-Meia paga parcela de R$ 1.000,00 a aprovados no ensino médio de 2026 entre fevereiro e março de 2027

  3. Política

    Com obstrução parcial no intestino, Jair Bolsonaro é internado no hospital DF Star em Brasília

  4. INSS

    Recuperação da senha Gov.br pelo celular exige reconhecimento facial ou código por SMS para o Meu INSS

  5. EUA

    Terremoto em Los Angeles atinge magnitude 4,2 e causa tremores leves em Commerce na madrugada

  6. Matéria Publicitária

    MineMV é o novo jogo grátis de construir com blocos; veja como jogar e liberado para todas as idades

  7. Política

    Regulamentação da escala 5×2 pelo governo encarece cálculo da hora extra a partir de 16 de dezembro

  8. Santa Catarina

    Acidente de trânsito na SC-108 envolve carro e moto e deixa motociclista morto em São Ludgero

  9. Mundo

    Jornalista italiano Corrado Augias morre aos 91 anos; presidente da Itália lamenta a perda

  10. Loterias

    Rendimento de R$ 40 milhões da Mega-Sena 3088 chega a R$ 337 mil por mês no Tesouro Direto